4Fortuno MA, Ravassa S, Fortuno A, et al. Cardiomyocyte apoptotic cell death in arterial Hypertension: mechanisms and potential mandgement.Hypertension,2001,38:1406 ～ 1412.
5Mallion J,Siche J, Lacourciere Y. ABPM Comparison of the antihypertensive profiles of the selective angiotensin Ⅱ receptor antagonists telmisartan and losartan in patients with mild - to - moderate hypertension, J Hum Hypertension, 1999,13 ( 1 ) :657 ～ 664.
2[2]Neutel JM. Use of ambulatory blood pressure monitoring to evaluate the selective angiotensinll receptor antagonist telmisartan, and other antihypertensive drugs [J]. Blood Press Monit,2000,5(suppl 1 ):S35-S40.
3[3]Mallion J,Siche J,Lacourciere Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin Ⅱ receptor antagonists telmisartan and losartan in patients with mild-to-moderate hypertension [ J ]. J Hum Hypertens. 1999. 13(10) :657-664.
4[4]Kolloch RE,Neutel JM,Plouin PF. Comparison of telmisartan monotheraphy with losartan + hydrochlorothiazide in mild-to-moderate hypertension [ J ]. J Hypertens,2000, 18 (suppl 2) :S 97.
5[5]Liulejohn TW. ABPM comparison of telmisartan and valsartan in patients with mild-to-moderate hypertension [ J ]. J Hypertens. 2000, 18( suppl 2 ): S97.
6[6]Burnier M,Maillard M. The comparative pharmacology of angiotensin Ⅱ receptor antagonists[ J]. Blood Press,2001,10(suppl 1 ) :6-11.
7[7]Neutel JM,Smith DHG. For the Telmisartan US Study Group. Dose response and antihypertensive efficacy of the AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension [ J ]. Adv Ther, 1998. 15 :206-217.
8[8]Luccourciere Y,Tytos R,O 'Keefe,et al. Efficacy and tolerability of a fixed-dose combinasion of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy [ J ]. J Hum Hypertens,2001, 15 ( 11 ) :763 -770.
9[9]Kulbertus H Pharma-clinics medieation of the month. Telmisartan (Micardis)[J]. Rev Med Liege,2000,55(3) :200(Abstract).
10[10]Lacourciere Y. The incidence of cough:a comparison of lisinopril.placebo and telmisartan,a novel angiotensin 11 antagonist. Telmisartan Cough Study Group [J]. Int J Clin Pract,1999,53(2) :99-103.
